Odyssey Therapeutics

Building a machine learning-based platform to develop novel therapeutics focusing on cancer and autoimmune diseases.

Launch date

Jun 2018

Employees

Market cap

Enterprise valuation

CAD1.5b (Public information from Dec 2023)

San Francisco California (HQ)

Revenues, earnings & profits over time

USD	2021	2023
Revenues	<1m	39.2m

Date	Investors	Amount	Round
Aug 2021	N/A	$91.6m	Early VC
Dec 2021*	SR One	$218m	Series A
Oct 2022*	General Catalyst Partners Fidelity Investments SR One Foresite Capital OrbiMed Alexandria Venture Investments GreatPoint Ventures Colt Ventures T. Rowe Price Logos Capital Creacion Ventures Catalio Capital Management Woodline Partners Walleye Capital HBM Healthcare Investments The Healthcare Innovation Investment Fund	$168m Valuation: $1.1b	Series B
Dec 2023*	General Catalyst Partners Fidelity Investments SR One Foresite Capital OrbiMed Alexandria Venture Investments KB Investment Colt Ventures Leerink Partners T. Rowe Price Creacion Ventures Catalio Capital Management Woodline Partners Walleye Capital HBM Healthcare Investments AB Magnitude Ventures BlackMars Capital Ascenta Capital Global BioAccess Fund Racing Beach Ventures	$101m Valuation: $1.1b	Series C
Total Funding		CAD789m

Tech stackLearn more about the technologies and tools that this company uses.

ACQUISITION by Odyssey Therapeutics Dec 2021

Financials